Paper · 42298331

Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients.

Degan C and 7 others. J Cachexia Sarcopenia Muscle, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients. Papers, record 42298331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42298331

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients.; PubMed
Journal: J Cachexia Sarcopenia Muscle; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Observational Study; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/42298331/; PubMed
DOI: https://doi.org/10.1002/jcsm.70320; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13269173/; PubMed
The journal: https://conductscience.org/library/journal-index/101552883; PubMed
Citations, by iCite: 1; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Degan C	Chiara	https://orcid.org/0009-0001-9993-9346
2	Tsonaka R	Roula	https://orcid.org/0000-0002-3466-5401
3	de Vries SI	Sharon I
4	Ikelaar NA	Nadine A	https://orcid.org/0000-0002-0609-4752
5	van der Holst M	Menno	https://orcid.org/0000-0002-0797-5711
6	Kan HE	Hermien E	https://orcid.org/0000-0002-5772-7177
7	Niks EH	Erik H	https://orcid.org/0000-0001-5892-5143
8	Spitali P	Pietro	https://orcid.org/0000-0003-2783-688X

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Muscular Dystrophy, Duchenne	Major topic
Biomarkers	Major topic
Myostatin	Major topic
Creatinine	Major topic
Creatine	Major topic
Muscle, Skeletal	Major topic
Humans
Child
Male
Longitudinal Studies
Child, Preschool
Adolescent
Disease Progression
Female

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
Project 22.010	Duchenne Parent Project NL			PubMed	PubMed
R61NS119639	NIH HHS	United States	R61NS119639	PubMed	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers
Update of	40,832,416	Creatine/creatinine ratio and myostatin as biomarkers to monitor muscle function in Duchenne Muscular Dystrophy patients.	https://conductscience.org/library/papers/40832416

Source PubMed

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	37,739,572	Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.	Lancet Neurol	2023	https://conductscience.org/library/papers/37739572	PubMed
2	37,119,051	LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer.	J Urol	2023	https://conductscience.org/library/papers/37119051	PubMed
3	32,390,640	Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.	J Neuromuscul Dis	2020	https://conductscience.org/library/papers/32390640	PubMed
4	33,602,943	Duchenne muscular dystrophy.	Nat Rev Dis Primers	2021	https://conductscience.org/library/papers/33602943	PubMed
5	33,751,844	Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients.	EMBO Mol Med	2021	https://conductscience.org/library/papers/33751844	PubMed
6	19,412,331	Myostatin in the pathophysiology of skeletal muscle.	Curr Genomics	2007	https://conductscience.org/library/papers/19412331	PubMed
7	34,151,852	The Minimal Clinical Important Difference (MCID) in Annual Rate of Change of Timed Function Tests in Boys with DMD.	J Neuromuscul Dis	2021	https://conductscience.org/library/papers/34151852	PubMed
8	28,074,267	Reduced serum myostatin concentrations associated with genetic muscle disease progression.	J Neurol	2017	https://conductscience.org/library/papers/28074267	PubMed
9	17,430,086	Creatine: endogenous metabolite, dietary, and therapeutic supplement.	Annu Rev Nutr	2007	https://conductscience.org/library/papers/17430086	PubMed
10	19,787,747	High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.	NMR Biomed	2010	https://conductscience.org/library/papers/19787747	PubMed

1 to 10 of 35

See all 35 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMID	Title	Journal	Year	In Papers	Source
42,443,978	Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.	Skelet Muscle	2026	https://conductscience.org/library/papers/42443978	PubMed
41,503,480	Evaluation of a serum protein signature as monitoring biomarker for Duchenne Muscular Dystrophy in a long-term clinical trial with corticosteroids.	medRxiv	2026	https://conductscience.org/library/papers/41503480	PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
MSTN	2,660	PubTator's text mining	https://conductscience.org/library/genes/2660

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42298331

GET https://conductscience.org/api/papers/v1/42298331/references?page=2

API reference For AI assistants